Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 5
1985 5
1986 6
1987 5
1988 13
1989 5
1990 8
1991 3
1992 6
1993 5
1994 13
1995 9
1996 15
1997 10
1998 7
1999 7
2000 8
2001 11
2002 5
2003 13
2004 8
2005 7
2006 7
2007 12
2008 9
2009 15
2010 12
2011 9
2012 13
2013 14
2014 14
2015 9
2016 15
2017 15
2018 12
2019 14
2020 18
2021 19
2022 10
2023 9
2024 5
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

377 results

Results by year

Filters applied: . Clear all
Page 1
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study.
Colombo N, Gadducci A, Landoni F, Lorusso D, Sabbatini R, Artioli G, Berardi R, Ceccherini R, Cecere SC, Cormio G, De Angelis C, Legge F, Lissoni A, Mammoliti S, Mangili G, Naglieri E, Petrella MC, Ricciardi GRR, Ronzino G, Salutari V, Sambataro D, Savarese A, Scandurra G, Tasca G, Tomao F, Valabrega G, Zavallone L, Pignata S. Colombo N, et al. Among authors: gadducci a. Gynecol Oncol. 2023 Aug;175:182-189. doi: 10.1016/j.ygyno.2023.05.065. Epub 2023 Jun 22. Gynecol Oncol. 2023. PMID: 37355448
Factors in malignant transformation of ovarian endometriosis: A narrative review.
Giannini A, Massimello F, Caretto M, Cosimi G, Mannella P, Luisi S, Gadducci A, Simoncini T. Giannini A, et al. Among authors: gadducci a. Gynecol Endocrinol. 2024 Dec;40(1):2409911. doi: 10.1080/09513590.2024.2409911. Epub 2024 Oct 24. Gynecol Endocrinol. 2024. PMID: 39445672 Free article. Review.
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial.
Pignata S, Lorusso D, Joly F, Gallo C, Colombo N, Sessa C, Bamias A, Salutari V, Selle F, Frezzini S, De Giorgi U, Pautier P, Bologna A, Orditura M, Dubot C, Gadducci A, Mammoliti S, Ray-Coquard I, Zafarana E, Breda E, Favier L, Ardizzoia A, Cinieri S, Largillier R, Sambataro D, Guardiola E, Lauria R, Pisano C, Raspagliesi F, Scambia G, Daniele G, Perrone F; MITO16b/MANGO–OV2/ENGOT–ov17 Investigators. Pignata S, et al. Among authors: gadducci a. Lancet Oncol. 2021 Feb;22(2):267-276. doi: 10.1016/S1470-2045(20)30637-9. Lancet Oncol. 2021. PMID: 33539744 Clinical Trial.
Harmonization of homologous recombination deficiency testing in ovarian cancer: Results from the MITO16A/MaNGO-OV2 trial.
Roma C, Esposito Abate R, Sacco A, Califano D, Arenare L, Bergantino F, Pisano C, Cecere SC, Scambia G, Lorusso D, Artioli G, Tasca G, Spina A, Russo D, Gadducci A, De Angelis C, Bologna A, Marchini S, Capoluongo ED, Perrone F, Pignata S, Normanno N. Roma C, et al. Among authors: gadducci a. Eur J Cancer. 2024 Jul;206:114127. doi: 10.1016/j.ejca.2024.114127. Epub 2024 May 23. Eur J Cancer. 2024. PMID: 38797038
Pharmacological treatment for uterine leiomyosarcomas.
Gadducci A, Guerrieri ME. Gadducci A, et al. Expert Opin Pharmacother. 2015 Feb;16(3):335-46. doi: 10.1517/14656566.2015.985205. Epub 2014 Nov 22. Expert Opin Pharmacother. 2015. PMID: 25418060 Review.
Cervical Adenocarcinoma: A Still Under-investigated Malignancy.
Pistolesi S, Fanelli GN, Giudice F, Garbini F, Naccarato AG, Cosio S, Caretto M, Gadducci A. Pistolesi S, et al. Among authors: gadducci a. Anticancer Res. 2023 Jan;43(1):53-58. doi: 10.21873/anticanres.16133. Anticancer Res. 2023. PMID: 36585201
377 results